Breast cancer prevention based on gene-environment interaction

Molecular Carcinogenesis

Volumn 50, Issue 4, 2011, Pages 280-290

  Song, Minkyo ^a   Lee, Kyoung Mu ^a,b   Kang, Daehee ^a,c  

^a Seoul National University College of Medicine   (South Korea)

^b Seoul National University Hospital   (South Korea)

^c Seoul National University   (South Korea)

Author keywords

Breast neoplasms; Environment; Gene; Interaction; Prevention

Indexed keywords

TRASTUZUMAB;

ALCOHOL CONSUMPTION; ARTICLE; BEHAVIOR MODIFICATION; BREAST CANCER; BREAST CARCINOGENESIS; CANCER GROWTH; CANCER RISK; CANCER STAGING; CANCER SUSCEPTIBILITY; CIGARETTE SMOKING; DIETARY INTAKE; EARLY DIAGNOSIS; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; EXERCISE; GENE INTERACTION; HEREDITY; HUMAN; MAMMOGRAPHY; OBESITY; PATIENT MONITORING; PHYSICAL ACTIVITY; PRIORITY JOURNAL;

BREAST NEOPLASMS; ENVIRONMENTAL EXPOSURE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LIFE STYLE; OBESITY; PRIMARY PREVENTION; RISK ASSESSMENT; RISK FACTORS;

EID: 79953320833     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.20639     Document Type: Article

References (91)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74-108.
2. Bray F, McCarron P, Parkin DM. The changing global patterns of female breast cancer incidence and mortality. Breast Cancer Res 2004; 6: 229-239.
3. Shimizu H, Ross RK, Bernstein L, Yatani R, Henderson BE, Mack TM. Cancers of the prostate and breast among Japanese and white immigrants in Los Angeles County. Br J Cancer 1991; 63: 963-966.
4. Deapen D, Liu L, Perkins C, Bernstein L, Ross RK. Rapidly rising breast cancer incidence rates among Asian-American women. Int J Cancer 2002; 99: 747-750.
5. Ziegler RG, Hoover RN, Pike MC, et al. Migration patterns and breast cancer risk in Asian-American women. J Natl Cancer Inst 1993; 85: 1819-1827.
6. King M-C. Gene-environment interactions in BRCA related breast cancer. In: NIH, editors. Genetic variation and gene environment interaction in human health and disease. 2003. pp. 9-10.
7. Rothman N, Wacholder S, Caporaso NE, Garcia-Closas M, Buetow K, Fraumeni JF, Jr. The use of common genetic polymorphisms to enhance the epidemiologic study of environmental carcinogens. Biochim Biophys Acta 2001; 1471: C1-C10.
8. Khoury MJ, Davis R, Gwinn M, Lindegren ML, Yoon P. Do we need genomic research for the prevention of common diseases with environmental causes? Am J Epidemiol 2005; 161: 799-805.
9. Shu XO, Moore DB, Cai Q, et al. Association of cyclin D1 genotype with breast cancer risk and survival. Cancer Epidemiol Biomarkers Prev 2005; 14: 91-97.
10. De Vivo I, Hankinson SE, Colditz GA, Hunter DJ. A functional polymorphism in the progesterone receptor gene is associated with an increase in breast cancer risk. Cancer Res 2003; 63: 5236-5238.
11. Visvanathan K, Crum RM, Strickland PT, et al. Alcohol dehydrogenase genetic polymorphisms, low-to-moderate alcohol consumption, and risk of breast cancer. Alcohol Clin Exp Res 2007; 31: 467-476.
12. He C, Tamimi RM, Hankinson SE, Hunter DJ, Han J. A prospective study of genetic polymorphism in MPO, antioxidant status, and breast cancer risk. Breast Cancer Res Treat 2009; 113: 585-594.
13. Tamimi RM, Hankinson SE, Spiegelman D, Colditz GA, Hunter DJ. Manganese superoxide dismutase polymorphism, plasma antioxidants, cigarette smoking, and risk of breast cancer. Cancer Epidemiol Biomarkers Prev 2004; 13: 989-996.
14. Shen J, Terry MB, Gammon MD, et al. MGMT genotype modulates the associations between cigarette smoking, dietary antioxidants and breast cancer risk. Carcinogenesis 2005; 26: 2131-2137.
15. Ahn J, Gammon MD, Santella RM, et al. Associations between breast cancer risk and the catalase genotype, fruit and vegetable consumption, and supplement use. Am J Epidemiol 2005; 162: 943-952.
16. Ahn J, Gammon MD, Santella RM, et al. Effects of glutathione S-transferase A1 (GSTA1) genotype and potential modifiers on breast cancer risk. Carcinogenesis 2006; 27: 1876-1882.
17. Li Y, Ambrosone CB, McCullough MJ, et al. Oxidative stress-related gen otypes, fruit and vegetable consumption and breast cancer risk. Carcinogenesis 2009; 30: 777-784.
18. Deitz AC, Zheng W, Leff MA, et al. N-Acetyltransferase-2 genetic polymorphism, well-done meat intake, and breast cancer risk among postmenopausal women. Cancer Epidemiol Biomarkers Prev 2000; 9: 905-910.
19. Ambrosone CB, Kropp S, Yang J, Yao S, Shields PG, Chang-Claude J. Cigarette smoking, N-acetyltransferase 2 genotypes, and breast cancer risk: Pooled analysis and meta-analysis. Cancer Epidemiol Biomarkers Prev 2008; 17: 15-26.
20. Vogl FD, Taioli E, Maugard C, et al. Glutathione S-transferases M1, T1, and P1 and breast cancer: A pooled analysis. Cancer Epidemiol Biomarkers Prev 2004; 13: 1473-1479.
21. Shen J, Gammon MD, Terry MB, et al. Polymorphisms in XRCC1 modify the association between polycyclic aromatic hydrocarbon-DNA adducts, cigarette smoking, dietary antioxidants, and breast cancer risk. Cancer Epidemiol Biomarkers Prev 2005; 14: 336-342.
22. Hunter DJ, Hankinson SE, Hough H, et al. A prospective study of NAT2 acetylation genotype, cigarette smoking, and risk of breast cancer. Carcinogenesis 1997; 18: 2127-2132.
23. Shore RE, Zeleniuch-Jacquotte A, Currie D, et al. Polymorphisms in XPC and ERCC2 genes, smoking and breast cancer risk. Int J Cancer 2008; 122: 2101-2105.
24. Modugno F, Zmuda JM, Potter D, et al. Association of estrogen receptor alpha polymorphisms with breast cancer risk in older Caucasian women. Int J Cancer 2005; 116: 984-991.
25. Pike MC, Pearce CL, Wu AH. Prevention of cancers of the breast, endometrium and ovary. Oncogene 2004; 23: 6379-6391.
26. Kolonel LN, Altshuler D, Henderson BE. The multiethnic cohort study: Exploring genes, lifestyle and cancer risk. Nat Rev Cancer 2004; 4: 519-527.
27. Hankinson SE, Colditz GA, Willett WC. Towards an integrated model for breast cancer etiology: The lifelong interplay of genes, lifestyle, and hormones. Breast Cancer Res 2004; 6: 213-218.
28. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 2003; 348: 1625-1638.
29. McTiernan A, Kooperberg C, White E, et al. Recreational physical activity and the risk of breast cancer in postmenopausal women: The Women's Health Initiative Cohort Study. JAMA 2003; 290: 1331-1336.
30. Terry P, Jain M, Miller AB, Howe GR, Rohan TE. No association among total dietary fiber, fiber fractions, and risk of breast cancer. Cancer Epidemiol Biomarkers Prev 2002; 11: 1507-1508.
31. Key TJ, Verkasalo PK, Banks E. Epidemiology of breast cancer. Lancet Oncol 2001; 2: 133-140.
32. van den Brandt PA, Spiegelman D, Yaun SS, et al. Pooled analysis of prospective cohort studies on height, weight, and breast cancer risk. Am J Epidemiol 2000; 152: 514-527.
33. Michels KB, Trichopoulos D, Robins JM, et al. Birthweight as a risk factor for breast cancer. Lancet 1996; 348: 1542-1546.
34. Smith-Warner SA, Spiegelman D, Yaun SS, et al. Alcohol and breast cancer in women: A pooled analysis of cohort studies. JAMA 1998; 279: 535-540.
35. Singletary KW, Gapstur SM. Alcohol and breast cancer: Review of epidemiologic and experimental evidence and potential mechanisms. JAMA 2001; 286: 2143-2151.
36. Michels KB, Mohllajee AP, Roset-Bahmanyar E, Beehler GP, Moysich KB. Diet and breast cancer: A review of the prospective observational studies. Cancer 2007; 109: 2712-2749.
37. Pierce JP, Natarajan L, Caan BJ, et al. Influence of a diet very high in vegetables, fruit, and fiber and low in fat on prognosis following treatment for breast cancer: The Women's Healthy Eating and Living (WHEL) randomized trial. JAMA 2007; 298: 289-298.
38. Knekt P, Steineck G, Jarvinen R, Hakulinen T, Aromaa A. Intake of fried meat and risk of cancer: A follow-up study in Finland. Int J Cancer 1994; 59: 756-760.
39. Zheng W, Gustafson DR, Sinha R, et al. Well-done meat intake and the risk of breast cancer. J Natl Cancer Inst 1998; 90: 1724-1729.
40. Terry PD, Rohan TE. Cigarette smoking and the risk of breast cancer in women: A review of the literature. Cancer Epidemiol Biomarkers Prev 2002; 11: 953-971.
41. Nagata C, Mizoue T, Tanaka K, et al. Tobacco smoking and breast cancer risk: An evaluation based on a systematic review of epidemiological evidence among the Japanese population. Jpn J Clin Oncol 2006; 36: 387-394.
42. Morabia A. Smoking (active and passive) and breast cancer: Epidemiologic evidence up to June 2001. Environ Mol Mutagen 2002; 39: 89-95.
43. Johnson KC. Accumulating evidence on passive and active smoking and breast cancer risk. Int J Cancer 2005; 117: 619-628.
44. Holmes MD, Murin S, Chen WY, Kroenke CH, Spiegelman D, Colditz GA. Smoking and survival after breast cancer diagnosis. Int J Cancer 2007; 120: 2672-2677.
45. Coyle YM. Lifestyle, genes, and cancer. Methods Mol Biol 2009; 472: 25-56.
46. Coyle YM. Physical activity as a negative modulator of estrogen-induced breast cancer. Cancer Causes Control 2008; 19: 1021-1029.
47. Monninkhof EM, Elias SG, Vlems FA, et al. Physical activity and breast cancer: A systematic review. Epidemiology 2007; 18: 137-157.
48. Holmes MD, Chen WY, Feskanich D, Kroenke CH, Colditz GA. Physical activity and survival after breast cancer diagnosis. JAMA 2005; 293: 2479-2486.
49. Holick CN, Newcomb PA, Trentham-Dietz A, et al. Physical activity and survival after diagnosis of invasive breast cancer. Cancer Epidemiol Biomarkers Prev 2008; 17: 379-386.
50. McTiernan A, Tworoger SS, Ulrich CM, et al. Effect of exercise on serum estrogens in postmenopausal women: A 12-month randomized clinical trial. Cancer Res 2004; 64: 2923-2928.
51. Helzlsouer KJ, Selmin O, Huang HY, et al. Association between glutathione S-transferase M1, P1, and T1 genetic polymorphisms and development of breast cancer. J Natl Cancer Inst 1998; 90: 512-518.
52. Rossner P, Jr., Terry MB, Gammon MD, et al. OGG1 polymorphisms and breast cancer risk. Cancer Epidemiol Biomarkers Prev 2006; 15: 811-815.
53. Pezzotti A, Kraft P, Hankinson SE, Hunter DJ, Buring J, Cox DG. The mitochondrial A10398G polymorphism, interaction with alcohol consumption, and breast cancer risk. PLoS One 2009; 4: e5356.
54. Vogel U, Christensen J, Nexo BA, Wallin H, Friis S, Tjonneland A. Peroxisome proliferator-activated [corrected] receptor-gamma2 [corrected] Pro12Ala, interaction with alcohol intake and NSAID use, in relation to risk of breast cancer in a prospective study of Danes. Carcinogenesis 2007; 28: 427-434.
55. Maruti SS, Ulrich CM, Jupe ER, White E. MTHFR C677T and postmenopausal breast cancer risk by intakes of one-carbon metabolism nutrients: A nested case-control study. Breast Cancer Res 2009; 11: R91.
56. Slanger TE, Chang-Claude J, Wang-Gohrke S. Manganese superoxide dismutase Ala-9Val polymorphism, environmental modifiers, and risk of breast cancer in a German population. Cancer Causes Control 2006; 17: 1025-1031.
57. Kim SU, Lee KM, Park SK, et al. Genetic polymorphism of glutathione S-transferase P1 and breast cancer risk. J Biochem Mol Biol 2004; 37: 582-585.
58. Park SK, Yoo KY, Lee SJ, et al. Alcohol consumption, glutathione S-transferase M1 and T1 genetic polymorphisms and breast cancer risk. Pharmacogenetics 2000; 10: 301-309.
59. Lee KM, Abel J, Ko Y, et al. Genetic polymorphisms of cytochrome P450 19 and 1B1, alcohol use, and breast cancer risk in Korean women. Br J Cancer 2003; 88: 675-678.
60. Choi JY, Abel J, Neuhaus T, et al. Role of alcohol and genetic polymorphisms of CYP2E1 and ALDH2 in breast cancer development. Pharmacogenetics 2003; 13: 67-72.
61. McCullough ML, Stevens VL, Diver WR, et al. Vitamin D pathway gene polymorphisms, diet, and risk of postmenopausal breast cancer: A nested case-control study. Breast Cancer Res 2007; 9: R9.
62. Han J, Hankinson SE, De Vivo I, et al. A prospective study of XRCC1 haplotypes and their interaction with plasma carotenoids on breast cancer risk. Cancer Res 2003; 63: 8536-8541.
63. Han J, Hankinson SE, Ranu H, De Vivo I, Hunter DJ. Polymorphisms in DNA double-strand break repair genes and breast cancer risk in the Nurses' Health Study. Carcinogenesis 2004; 25: 189-195.
64. Ericson U, Sonestedt E, Ivarsson MI, et al. Folate intake, methylenetetrahydrofolate reductase polymorphisms, and breast cancer risk in women from the Malmo Diet and Cancer cohort. Cancer Epidemiol Biomarkers Prev 2009; 18: 1101-1110.
65. Egeberg R, Olsen A, Autrup H, et al. Meat consumption, N-acetyl transferase 1 and 2 polymorphism and risk of breast cancer in Danish postmenopausal women. Eur J Cancer Prev 2008; 17: 39-47.
66. Yuan JM, Koh WP, Sun CL, Lee HP, Yu MC. Green tea intake, ACE gene polymorphism and breast cancer risk among Chinese women in Singapore. Carcinogenesis 2005; 26: 1389-1394.
67. Thiebaut AC, Kipnis V, Schatzkin A, Freedman LS. The role of dietary measurement error in investigating the hypothesized link between dietary fat intake and breast cancer-A story with twists and turns. Cancer Invest 2008; 26: 68-73.
68. Alberg AJ, Daudt A, Huang HY, et al. N-acetyltransferase 2 (NAT2) genotypes, cigarette smoking, and the risk of breast cancer. Cancer Detect Prev 2004; 28: 187-193.
69. Mechanic LE, Millikan RC, Player J, et al. Polymorphisms in nucleotide excision repair genes, smoking and breast cancer in African Americans and whites: A population-based case-control study. Carcinogenesis 2006; 27: 1377-1385.
70. Kawase T, Matsuo K, Suzuki T, et al. FGFR2 intronic polymorphisms interact with reproductive risk factors of breast cancer: Results of a case control study in Japan. Int J Cancer 2009; 125: 1946-1952.
71. Olsen A, Autrup H, Sorensen M, Overvad K, Tjonneland A. Polymorphisms of glutathione S-transferase A1 and O1 and breast cancer among postmenopausal Danish women. Eur J Cancer Prev 2008; 17: 225-229.
72. Terry PD, Goodman M. Is the association between cigarette smoking and breast cancer modified by genotype? A review of epidemiologic studies and meta-analysis. Cancer Epidemiol Biomarkers Prev 2006; 15: 602-611.
73. Gail MH, Brinton LA, Byar DP, et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 1989; 81: 1879-1886.
74. Claus EB, Risch N, Thompson WD. Autosomal dominant inheritance of early-onset breast cancer. Implications for risk prediction. Cancer 1994; 73: 643-651.
75. Huo D, Senie RT, Daly M, et al. Prediction of BRCA mutations using the BRCAPRO model in clinic-based African American, Hispanic, and other minority families in the United States. J Clin Oncol 2009; 27: 1184-1190.
76. Armstrong K, Eisen A, Weber B. Assessing the risk of breast cancer. N Engl J Med 2000; 342: 564-571.
77. King MC, Marks JH, Mandell JB. Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science 2003; 302: 643-646.
78. Kriege M, Brekelmans CT, Boetes C, et al. Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. N Engl J Med 2004; 351: 427-437.
79. Rebbeck TR, Friebel T, Lynch HT, et al. Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: The PROSE Study Group. J Clin Oncol 2004; 22: 1055-1062.
80. Duffy MJ. Serum tumor markers in breast cancer: Are they of clinical value? Clin Chem 2006; 52: 345-351.
81. Brooks M. Breast cancer screening and biomarkers. Methods Mol Biol 2009; 472: 307-321.
82. Fabian CJ, Kimler BF, Zalles CM, et al. Short-term breast cancer prediction by random periareolar fine-needle aspiration cytology and the Gail risk model. J Natl Cancer Inst 2000; 92: 1217-1227.
83. McClelland RA, Berger U, Miller LS, Powles TJ, Coombes RC. Immunocytochemical assay for estrogen receptor in patients with breast cancer: Relationship to a biochemical assay and to outcome of therapy. J Clin Oncol 1986; 4: 1171-1176.
84. Fornier M, Risio M, Van Poznak C, Seidman A. HER2 testing and correlation with efficacy of trastuzumab therapy. Oncology (Williston Park) 2002; 16: 1340-1348, 1351-1342; discussion 1352, 1355-1348.
85. Pusztai L, Rouzier R, Wagner P, Symmans WF. Individualized chemotherapy treatment for breast cancer: Is it necessary? Is it feasible? Drug Resist Updat 2004; 7: 325-331.
86. Lu H, Shu XO, Cui Y, et al. Association of genetic polymorphisms in the VEGF gene with breast cancer survival. Cancer Res 2005; 65: 5015-5019.
87. Zheng W. Genetic polymorphisms in the transforming growth factor-beta signaling pathways and breast cancer risk and survival. Methods Mol Biol 2009; 472: 265-277.
88. Choi JY, Lee KM, Park SK, et al. Genetic polymorphisms of SULT1A1 and SULT1E1 and the risk and survival of breast cancer. Cancer Epidemiol Biomarkers Prev 2005; 14: 1090-1095.
89. Kellen E, Vansant G, Christiaens MR, Neven P, Van Limbergen E. Lifestyle changes and breast cancer prognosis: A review. Breast Cancer Res Treat 2009; 114: 13-22.
90. Tempfer CB, Hefler LA, Schneeberger C, Huber JC. How valid is single nucleotide polymorphism (SNP) diagnosis for the individual risk assessment of breast cancer? Gynecol Endocrinol 2006; 22: 155-159.
91. Shen J. Evaluation of environmental and personal susceptibility characteristics that modify genetic risks. Methods Mol Biol 2009; 471: 163-177.